[74] Despite this, targeting the cytokine has been shown to reduce inflammation; a mouse model demonstrated that anti-IFN-γ treatment introduced at initial stages of uveitis is protective, attenuating the disease process. The gene discussed is IFNG; the disease is uveitis.